Arvinas, Inc. (ARVN) vs Crescent Biopharma, Inc. (CBIO)

Arvinas, Inc. and Crescent Biopharma, Inc. are both Biotechnology companies. Arvinas, Inc. and Crescent Biopharma, Inc. are of similar size ($528.9M and $509.4M). Crescent Biopharma, Inc. has negative trailing earnings, so its P/E is not meaningful; Arvinas, Inc. trades at 58.3×. Arvinas, Inc. grew revenue faster over the last twelve months: −15.1% against −45.1%. Arvinas, Inc. has the higher net margin (2.94% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Arvinas, Inc. leads on 10 and Crescent Biopharma, Inc. on 7.

Valuation

Metric ARVN CBIO Biotechnology median
P/E 58.31 n/m 7.88
P/S 1.55 350.63 11.47
P/B 0.87 2.68 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 4.20 n/m 0.74
EV/Sales (0.24) 240.54 10.73
Earnings yield 1.72% (48.03%) (28.84%)
Free cash flow yield (42.51%) (16.82%) (23.03%)

Profitability

Metric ARVN CBIO Biotechnology median
Gross margin 97.16% 19.72% 65.16%
Operating margin (5.72%) 0.00% 0.00%
Net margin 2.94% 0.00% 0.00%
Free cash flow margin (65.93%) 0.00% 0.00%
Return on equity 1.59% (112.14%) (57.72%)
Return on assets 1.17% (97.08%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ARVN CBIO Biotechnology median
Revenue growth (TTM) (15.05%) (45.09%) 5.64%
EPS growth (last fiscal year) 58.84% 44.97% —
Revenue growth, 5-year CAGR 58.93% 257.77% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARVN CBIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.91 9.66 4.73
Net debt to EBITDA 5.62 1.40 0.96

Dividend

Metric ARVN CBIO Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ARVN CBIO Biotechnology median
Market cap 509.36m 528.93m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack